These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20267003)

  • 1. British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.
    PETERS RA; BENNET J
    Br Med J; 1947 Oct; 2(4526):520. PubMed ID: 20267003
    [No Abstract]   [Full Text] [Related]  

  • 2. British anti-lewisite; its use and therapeutic value in arsenical intoxications.
    PETERS RA; BENNET J
    Lancet; 1947 Oct; 2(6475):497. PubMed ID: 20265166
    [No Abstract]   [Full Text] [Related]  

  • 3. [B.A.L treatment of arsenical poisoning].
    MIGNOLET F; HEUSGHEM C; BACQ ZM
    Acta Clin Belg; 1947; 2():199-204. PubMed ID: 20269203
    [No Abstract]   [Full Text] [Related]  

  • 4. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of lewisite and other arsenical vesicant lesions of the eyes of rabbits with British anti-lewisite (BAL).
    MANN I; PIRIE A; PULLINGER BD
    Am J Ophthalmol; 1947 Apr; 30(4):421-35. PubMed ID: 20256316
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
    Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical injury in arsenical intoxication and the British Anti-Lewisite].
    PETERS RA
    Rev Med Liege; 1948 Dec; 3(23):687-98. PubMed ID: 18100780
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 9. Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL).
    Snider TH; Wientjes MG; Joiner RL; Fisher GL
    Fundam Appl Toxicol; 1990 Feb; 14(2):262-72. PubMed ID: 2318351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BAL in the treatment of intoxication by arsenical and gold preparations].
    BERMUDEZ ABREU VP
    Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436
    [No Abstract]   [Full Text] [Related]  

  • 11. British anti-lewisite (BAL).
    PETERS RA; STOCKEN LA; THOMPSON RH
    Nature; 1945; 156():616-9. PubMed ID: 21006485
    [No Abstract]   [Full Text] [Related]  

  • 12. Bal (British anti-lewisite).
    WATERS LL; STOCK C
    Science; 1945 Dec; 102(2658):601-6. PubMed ID: 21004953
    [No Abstract]   [Full Text] [Related]  

  • 13. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 15. British anti-Lewisite (dimercaprol): an amazing history.
    Vilensky JA; Redman K
    Ann Emerg Med; 2003 Mar; 41(3):378-83. PubMed ID: 12605205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases.
    De OREO GA
    Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 18. British anti-lewisite. I. The biochemistry of arsenic.
    PETERS RA
    J R Inst Public Health; 1952 Apr; 15(4):89-103. PubMed ID: 14918249
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 20. [Two cases of severe arsenical erythroderma, successfully treated with the new BAL compound].
    NOGUER-MORE
    Actas Dermosifiliogr; 1948 Jan; 39(4):498-507. PubMed ID: 18865721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.